Paper11936701
Estimating the starting dose for entry into humans: principles and practice.
Reigner BG and 1 other. Eur J Clin Pharmacol, 2002. Cited by 89 papers, by iCite.
Cite this record
ConductScience Library. Estimating the starting dose for entry into humans: principles and practice. Papers, record 11936701. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11936701
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pharmaceutical Preparations | Major topic |
| Pharmacokinetics | Major topic |
| Animals | |
| Antineoplastic Agents | |
| Drug Industry | |
| Humans | |
| Maximum Tolerated Dose | |
| No-Observed-Adverse-Effect Level |
Source PubMed
Cited by45
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42682178 | Physiologically Based Pharmacokinetic Modeling to Predict Human Starting Dose and Pharmacokinetics for Rocbrutinib. | Clin Transl Sci | 2026 | https://conductscience.org/library/papers/42682178 | PubMed |
| 42666965 | Risk Management in First-in-Human Trials of Intravenous Drugs: Current Practices and Future Perspectives. | Ther Clin Risk Manag | 2026 | https://conductscience.org/library/papers/42666965 | PubMed |
| 42514940 | First-in-Human Dose Selection, Pharmacokinetics Prediction, and Clinical Validation of SYHA1805, a Novel FXR Agonist, Using Allometric Scaling and PBPK Modeling. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514940 | PubMed |
| 42500957 | Comparative validation of LC-MS, micro-bioassay, and ELISA for lincomycin quantification: application to pharmacokinetic analysis in healthy and co-infected porcine models. | Vet Q | 2026 | https://conductscience.org/library/papers/42500957 | PubMed |
| 42418317 | Predicting First-in-Human Pharmacokinetics: Comparative Evaluation of Standard PBPK, High-Throughput PBPK, and Machine Learning. | Mol Pharm | 2026 | https://conductscience.org/library/papers/42418317 | PubMed |
| 41898218 | Intranasal Drug Delivery in Neuropharmacology: Advances in Brain-Targeted Therapies and Bioethical Challenges. | Biomedicines | 2026 | https://conductscience.org/library/papers/41898218 | PubMed |
| 40760081 | The Parkinson's drug benztropine possesses histamine receptor 1-dependent host-directed antimicrobial activity against Mycobacterium tuberculosis. | NPJ Antimicrob Resist | 2025 | https://conductscience.org/library/papers/40760081 | PubMed |
| 39833376 | Effects of psychedelics on opioid use disorder: a scoping review of preclinical studies. | Cell Mol Life Sci | 2025 | https://conductscience.org/library/papers/39833376 | PubMed |
| 39304595 | Prediction of First-in-Human Dose of Chimeric Antigen Receptor-T (CAR-T) Cells from Mice. | Eur J Drug Metab Pharmacokinet | 2024 | https://conductscience.org/library/papers/39304595 | PubMed |
| 39280932 | Effects of maternal nonylphenol exposure on the proliferation of glial cells in the brain of male offspring mice. | Anim Cells Syst (Seoul) | 2024 | https://conductscience.org/library/papers/39280932 | PubMed |
| 38251163 | Neuroprotective Effect of Solid Lipid Nanoparticles Loaded with Lepidium sativum (L.) Seed Bioactive Components Enhance Bioavailability and Wnt/β-Catenin/Camk-II Signaling Cascade in SH-SY5Y Neuroblastoma Cells. | Nanomaterials (Basel) | 2024 | https://conductscience.org/library/papers/38251163 | PubMed |
| 38126024 | Mathematical modeling of cancer immunotherapy for personalized clinical translation. | Nat Comput Sci | 2022 | https://conductscience.org/library/papers/38126024 | PubMed |
| 35688844 | Testicular ultrastructure and hormonal changes following administration of tenofovir disoproxil fumarate-loaded silver nanoparticle in type-2 diabetic rats. | Sci Rep | 2022 | https://conductscience.org/library/papers/35688844 | PubMed |
| 35592432 | Rapamycin in Cerebral Cavernous Malformations: What Doses to Test in Mice and Humans. | ACS Pharmacol Transl Sci | 2022 | https://conductscience.org/library/papers/35592432 | PubMed |
| 35382850 | Propranolol as therapy for cerebral cavernous malformations: a cautionary note. | J Transl Med | 2022 | https://conductscience.org/library/papers/35382850 | PubMed |
| 34917828 | Highly active antiretroviral therapy conjugated silver nanoparticle ameliorates testicular injury in type-2 diabetic rats. | Heliyon | 2021 | https://conductscience.org/library/papers/34917828 | PubMed |
| 34849651 | Randomized Trial of Metformin With Anti-Tuberculosis Drugs for Early Sputum Conversion in Adults With Pulmonary Tuberculosis. | Clin Infect Dis | 2022 | https://conductscience.org/library/papers/34849651 | PubMed |
| 34562983 | A Single Animal Species-Based Prediction of Human Clearance and First-in-Human Dose of Monoclonal Antibodies: Beyond Monkey. | Antibodies (Basel) | 2021 | https://conductscience.org/library/papers/34562983 | PubMed |
| 34120326 | Comparison of Various Approaches to Translate Non-Linear Pharmacokinetics of Monoclonal Antibodies from Cynomolgus Monkey to Human. | Eur J Drug Metab Pharmacokinet | 2021 | https://conductscience.org/library/papers/34120326 | PubMed |
| 33922017 | The Use of Translational Modelling and Simulation to Develop Immunomodulatory Therapy as an Adjunct to Antibiotic Treatment in the Context of Pneumonia. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/33922017 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11936701
GET https://conductscience.org/api/papers/v1/11936701/cited_by?page=2